Search Count: 358
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-07-16 Classification: ANTITUMOR PROTEIN Ligands: A1EG3 |
 |
Crystal Structure Of Hdm2 In Complex With A Peptidic Ligand Containing A Di-Urea Insert.
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-07-02 Classification: ANTITUMOR PROTEIN Ligands: PO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ANTITUMOR PROTEIN/INHIBITOR Ligands: ZN, GOL, A1LUZ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ANTITUMOR PROTEIN/INHIBITOR Ligands: ZN, A1LU0 |
 |
Local Refinement Structure Of Segfr And 528 Fv (From Hl-Type Bispecific Diabody Ex3) Complex
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Poly-Alanine Model For Hl-Type Bispecific Diabody Ex3 Composed Of 528 And Okt3 Fvs In Ternary Complex With Segfr And Cd3Gamma-Epsilon (Closed Conformation)
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Poly-Alanine Model For Hl-Type Bispecific Diabody Ex3 Composed Of 528 And Okt3 Fvs In Ternary Complex With Segfr And Cd3Gamma-Epsilon (Middle Conformation)
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Poly-Alanine Model For Hl-Type Bispecific Diabody Ex3 Composed Of 528 And Okt3 Fvs In Ternary Complex With Segfr And Cd3Gamma-Epsilon (Open Conformation)
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Local Refinement Structure Of Segfr And 528 Fv (From Lh-Type Bispecific Diabody Ex3) Complex
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Poly-Alanine Model For Lh-Type Bispecific Diabody Ex3 Composed Of 528 And Okt3 Fvs In Ternary Complex With Segfr And Cd3Gamma-Epsilon (Closed Conformation)
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Poly-Alanine Model For Lh-Type Bispecific Diabody Ex3 Composed Of 528 And Okt3 Fvs In Ternary Complex With Segfr And Cd3Gamma-Epsilon (Middle Conformation)
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Poly-Alanine Model For Lh-Type Bispecific Diabody Ex3 Composed Of 528 And Okt3 Fvs In Ternary Complex With Segfr And Cd3Gamma-Epsilon (Open Conformation)
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Organism: Lama glama
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2025-04-16 Classification: ANTITUMOR PROTEIN Ligands: SO4, GOL, ACT |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.67 Å Release Date: 2025-03-19 Classification: HYDROLASE Ligands: A1LZN |
 |
Crystal Structure Of Engineered Ipilimumab (Mipi.4) Fab In Complex With Human Ctla-4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2025-02-05 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Crystal Structure Of Engineered Ipilimumab (Mipi.4) Fab In Complex With Mouse Ctla-4
Organism: Mus musculus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2025-02-05 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Organism: Homo sapiens, Mus musculus
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2025-02-05 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-12-25 Classification: ANTITUMOR PROTEIN Ligands: A1LVL, SAM |
 |
Fully Human Monoclonal Antibody Targeting The Cysteine-Rich Substrate-Interacting Region Of Adam17 On Cancer Cells.
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-11-20 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Development Of 2-Imino-2,3,5,6,7,8-Hexahydropyrido[4,3-D]Pyrimidin-4(1H)-One Derivatives As Human Caseinolytic Peptidase P (Hclpp) Activators
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2024-10-23 Classification: HYDROLASE Ligands: XFU, BR |